Prevention of aGVHD
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation (NCT04014790) | Regimmune Corporation | 2019-11-25 |
Track Prevention of aGVHD automatically
Every clearance here is in the API, with alerts when new ones post.